Skip to content

New Zealand logo

Main menu
  • Home
  • Our Products

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Our Products

This page is intended for use by New Zealand healthcare professionals only and intended for use by consumers for the Consumer Medical Information (CMI), and healthcare professionals for the Data Sheet and CMI. The information is not intended to replace the advice of a healthcare professional and if you are a consumer, the CMI is not medical advice. Any information provided by this source and any medical questions should be referred and discussed with a healthcare professional.

ARCOXIA® etoricoxib
Consumer Medicine Information                                        Data Sheet

CELESTONE CHRONODOSE® betamethasone [acetate + sodium phosphate] injection
Consumer Medicine Information                                        Data Sheet

CERAZETTE® desogestrel
Consumer Medicine Information                                        Data Sheet

DIPROSONE® betamethasone dipropionate
Consumer Medicine Information                                        Data Sheet

DIPROSONE OV® betamethasone dipropionate
Consumer Medicine Information                                        Data Sheet

ELOCON® mometasone furoate
Consumer Medicine Information                                        Data Sheet

ELONVA® corifollitropin alfa
Consumer Medicine Information                                        Data Sheet

FOSAMAX® alendronate
Consumer Medicine Information                                        Data Sheet

FOSAMAX PLUS® alendronate sodium/colecalciferol
Consumer Medicine Information                                        Data Sheet

LIVIAL® tibolone
Consumer Medicine Information                                        Data Sheet

MERCILON 28® ethinylestradiol/desogestrel
Consumer Medicine Information                                        Data Sheet

ORGALUTRAN® ganirelix
Consumer Medicine Information                                        Data Sheet

PROPECIA® finasteride
Consumer Medicine Information                                        Data Sheet

PUREGON® follitropin beta
Consumer Medicine Information                                        Data Sheet

RENITEC® enalapril maleate
Consumer Medicine Information                                        Data Sheet

SINEMET® carbidopa and levodopa
Consumer Medicine Information                                        Data Sheet

SINEMET CR® carbidopa and levodopa
Consumer Medicine Information                                        Data Sheet

To report an Adverse Event or Product Quality Complaint, or if you have a Medical Information enquiry about a specific Organon product, please call 0800 111 700.

New Zealand logo
  • Cookie Policy
  • Forward looking statement
  • Privacy Policy
  • Terms of use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept